Thiry E, Muylkens B, Meurens F, Gogev S, Thiry J, Vanderplasschen A, Schynts F
Department of Infectious and Parasitic Diseases, Virology and Immunology, Faculty of Veterinary Medicine, University of Liège, Bd de Colonster 20, B43b, B-4000 Liège, Belgium.
Vet Microbiol. 2006 Mar 31;113(3-4):171-7. doi: 10.1016/j.vetmic.2005.11.012. Epub 2005 Dec 15.
Herpesviruses are DNA viruses characterized by a low rate of nucleotide substitution. Therefore, other mechanisms must be involved to their evolution, like recombination that can be seen as an essential evolutionary driving force of these viruses. Recombination contributes to the long-term evolution of alphaherpesviruses. It acts also to continuously create new alphaherpesvirus strains. We have used bovine herpesvirus 1 to investigate recombination both within DNA concatemers in infected cells and in vitro and in vivo at the end of the lytic cycle. The following results have been obtained: (i) intramolecular recombination occurs at the level of concatemers and gives rise to genomic segment inversions; (ii) intraspecific recombination occurs frequently both in vitro and in vivo; (iii) interspecific recombination is possible and requires two highly genetically related viruses; (iv) only simultaneous or closely separated infections lead to the production of recombinant viruses; (v) recombination between wild-type and glycoprotein defective vaccine virus can produce a glycoprotein defective virus keeping part of the virulence of parental wild-type virus. Recombination, by exchanging genomic segments, may modify the virulence of alphaherpesviruses. It must be carefully assessed for the biosafety of antiviral therapy, alphaherpesvirus-based vectors and live attenuated vaccines.
疱疹病毒是一类DNA病毒,其核苷酸替换率较低。因此,它们的进化必定涉及其他机制,比如重组,而重组可被视为这些病毒重要的进化驱动力。重组有助于甲型疱疹病毒的长期进化。它还能持续产生新的甲型疱疹病毒毒株。我们利用牛疱疹病毒1来研究感染细胞内DNA串联体内部以及裂解周期末期在体外和体内的重组情况。获得了以下结果:(i)分子内重组发生在串联体水平,导致基因组片段倒位;(ii)种内重组在体外和体内均频繁发生;(iii)种间重组是可能的,且需要两种高度遗传相关的病毒;(iv)只有同时感染或间隔很近的感染才会产生重组病毒;(v)野生型与糖蛋白缺陷型疫苗病毒之间的重组可产生一种糖蛋白缺陷型病毒,该病毒保留了亲本野生型病毒的部分毒力。通过交换基因组片段,重组可能会改变甲型疱疹病毒的毒力。对于抗病毒治疗、基于甲型疱疹病毒的载体以及减毒活疫苗的生物安全性,必须进行仔细评估。